The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  1989-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JAC/24.3.295PMID 2681116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Successful treatment of melioidosis caused by a multiresistant strain in an immunocompromised host with third generation cephalosporins.

  2015cited by this paper
• Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand.

  1989cited by this paper
• Acute suppurative parotitis caused by Pseudomonas pseudomallei in children.

  1989cited by this paper
• Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE.

  1989cited by this paper
• Intraphagocytic penetration of antibiotics.

  1988cited by this paper
• Susceptibility of Pseudomonas pseudomallei to new beta-lactam and aminoglycoside antibiotics.

  1988cited by this paper
• Activities of five new fluoroquinolones against Pseudomonas pseudomallei

  1988cited by this paper
• Melioidosis in Bangladesh: a case report.

  1988cited by this paper
• Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins

  1988cited by this paper
• Antibiotic resistance in Pseudomonas pseudomallei.

  1988cited by this paper
• Mutation of Salmonella paratyphi A conferring cross-resistance to several groups of antibiotics by decreased permeability and loss of invasiveness

  1988cited by this paper
• In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei

  1988cited by this paper
• Clinical and laboratory studies of malaria and melioidosis.

  1988cited by this paper
• In-vitro susceptibility of Pseudomonas pseudomallei to DNA gyrase inhibitors.

  1987cited by this paper
• Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein.

  1987cited by this paper
• Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis

  1987cited by this paper
• Antimicrobial susceptibility of Pseudomonas pseudomallei.

  1987cited by this paper
• beta-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance.

  1987cited by this paper
• In vitro susceptibility of strains of Pseudomonas pseudomallei isolated in Thailand and Hong Kong to some newer beta-lactam antibiotics and quinolone derivatives.

  1986cited by this paper
• Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.

  1985cited by this paper
• In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates

  1984cited by this paper
• In vitro activity of various cephalosporins against Pseudomonas pseudomallei.

  1984cited by this paper
• Melioidosis: recrudescence with a strain resistant to multiple antimicrobials.

  1983cited by this paper
• TETRACYCLINE

  1979cited by this paper
• EVALUATION OF ANTIBIOTICS IN PSEUDOMONAS INFECTIONS

  1979cited by this paper
• Treatment of pulmonary melioidosis with combination of trimethoprim and sulfamethoxazole.

  1978cited by this paper
• Trimethoprim-sulfamethoxazole therapy of pulmonary melioidosis.

  1976cited by this paper
• Inhibition of Pseudomonas pseudomallei by carbenicillin, in vitro.

  1974cited by this paper
• Antibiotic Susceptibility of Pseudomonas pseudomallei

  1973cited by this paper
• Susceptibility in vitro and in vivo of Pseudomonas pseudomallei to rifampin and tetracyclines.

  1971cited by this paper
• The sensitivity of Pseudomonas pseudomallei to trimethoprim and sulphamethoxazole in vitro

  1971cited by this paper
• In vitro susceptibility of strains of Pseudomonas pseudomallei to rifampin.

  1971cited by this paper
• Pseudomonas pseudomallei: susceptibility to chemotherapeutic agents.

  1970cited by this paper
• The control of experimental infection in mice produced by Pseudomonas pseudomallei.

  1969cited by this paper
• [Acquired resistance of Whitmore bacillus to chloramphenicol, aureomycin and terramycin in vitro and in vivo].

  1955cited by this paper

• Melioidosis vaccines: recent advances and future directions

  2025cites this paper
• Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options

  2025cites this paper
• Ceftazidime-resistance in pediatric melioidosis: A case report and literature review

  2025cites this paper
• Targeting intracellular of populations Pseudomonas aeruginosa with peptide-mimetic therapies: individual efficacy and synergistic rescue of obsolete antibiotics

  2025cites this paper
• Electrochemical Immunoassay for Capturing Capsular Polysaccharide of Burkholderia pseudomallei: Early Onsite Detection of Melioidosis.

  2024cites this paper
• Identification and mechanism determination of the efflux pump subunit amrB gene mutations linked to gentamicin susceptibility in clinical Burkholderia pseudomallei from Malaysian Borneo

  2024cites this paper
• Meropenem-resistant Burkholderia pseudomallei: a concerning single case in Australia with no prior meropenem exposure

  2024cites this paper
• Effective Therapeutic Options for Melioidosis: Antibiotics versus Phage Therapy

  2022cites this paper
• Primary prostatic melioidosis: a diagnostic consideration for persisting prostatitis in Northern Australia

  2022cites this paper
• The Epidemiology of Melioidosis and Its Association with Diabetes Mellitus: A Systematic Review and Meta-Analysis

  2022cites this paper
• Clinical, Epidemiological and Microbiological Profile of A Potentially Pathogenic Environmental Saprophyte, Burkholderia pseudomallei; at A Tertiary Care Hospital in Coastal India

  2022cites this paper
• Thermal and gastric stability of antimicrobial activity of juices and aqueous extracts prepared from common eligible herbs and traditional medicinal plants against Burkholderia pseudomallei and other enteric bacteria

  2022cites this paper
• Genomic and RT-qPCR analysis of trimethoprim-sulfamethoxazole and meropenem resistance in Burkholderia pseudomallei clinical isolates

  2021cites this paper
• Antimicrobial Susceptibility of Western Hemisphere Isolates of Burkholderia pseudomallei: Phenotypic and Genomic Analyses

  2021influential citation
• Melioidosis: An emerging infection in India

  2021cites this paper
• Journal Pre-proof Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off (ECOFF) values

  2020cites this paper
• Class D β-lactamases.

  2020cites this paper
• Safer In Vitro Drug Screening Models for Melioidosis Therapy Development.

  2020cites this paper
• Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off (ECOFF) values.

  2020cites this paper
• Drug susceptibility profiling of Australian Burkholderia species as models for developing melioidosis therapeutics

  2020cites this paper
• Human Melioidosis

  2020cites this paper
• Correlation Between Etest and Reference Broth Microdilution for Antimicrobial Susceptibility Testing of Burkholderia pseudomallei

  2020cites this paper
• Presence of environmental Burkholderia pseudomallei and burden of melioidosis in Thailand

  2019cites this paper
• Deletion of Two Genes in Burkholderia pseudomallei MSHR668 That Target Essential Amino Acids Protect Acutely Infected BALB/c Mice and Promote Long Term Survival

  2019cites this paper
• Other Pathogens

  2019cites this paper
• Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei.

  2018cites this paper
• Development and validation of a triplex qPCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei

  2018cites this paper
• Antibiotics susceptibility of Burkholderia species of Sarawak origin

  2018cites this paper
• Isolation and Identification of Burkholderia mallei and its Susceptibility to Anethum graveolens Extracts

  2018cites this paper
• Calprotectin as a Biomarker for Melioidosis Disease Progression and Management

  2017cites this paper
• Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis

  2017cites this paper
• Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei

  2017cites this paper
• Loss of methyltransferase function and increased efflux activity leads to 1 doxycycline resistance in Burkholderia pseudomallei 2 3 4

  2017cites this paper
• CHALLENGES IN THE DIAGNOSIS AND TREATMENT OF MELIOIDOSIS: A REVIEW

  2017cites this paper
• Assessing the potential for Burkholderia pseudomallei in the southeastern United States.

  2017cites this paper
• Assessing the potential for Burkholderia pseudomallei in the southeastern United States Agent Burkholderia

  2016cites this paper
• Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.

  2016cites this paper
• Experimental Phage Therapy for Burkholderia pseudomallei Infection

  2016cites this paper
• Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease.

  2016cites this paper
• In silico identification of metabolic enzyme drug targets in Burkholderia pseudomallei

  2015cites this paper
• Melioidosis: Evolving Concepts in Epidemiology, Pathogenesis, and Treatment

  2015cites this paper
• Manipulation of antigen presenting cells to enhance host immune responses to bacterial infection

  2015cites this paper
• Drug susceptibility and biofilm formation of Burkholderia pseudomallei in nutrient-limited condition.

  2015cites this paper
• Meliodosis - A Lethal Trap for the Unwary

  2015cites this paper
• Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial

  2014cites this paper
• Whitmore's disease: an uncommon urological presentation

  2014cites this paper
• Melioidosis: a review.

  2014cites this paper
• Antimicrobial Susceptibility and Genetic Characterisation of Burkholderia pseudomallei Isolated from Malaysian Patients

  2014cites this paper
• REV IEW Melioidosis : a review

  2014cites this paper
• Treatment and prophylaxis of melioidosis

  2014influential citation
• Functional Characterization and Evaluation of In Vitro Protective Efficacy of Murine Monoclonal Antibodies BURK24 and BURK37 against Burkholderia pseudomallei

  2014cites this paper
• A REVIEW ON MELIOIDOSIS

  2013cites this paper
• Interplay between Three RND Efflux Pumps in Doxycycline-Selected Strains of Burkholderia thailandensis

  2013cites this paper
• An Improved Selective Culture Medium Enhances the Isolation of Burkholderia pseudomallei from Contaminated Specimens

  2013cites this paper
• Chronic suppurative joint effusion due to burkholderia pseudomallei: a case report.

  2013cites this paper
• Delineating the Immune Mechanisms Required by Murine Neutrophils and Macrophages for Clearance of Burkholderia pseudomallei , the Causative Agent of Melioidosis

  2013cites this paper
• Total protein extraction and 2-D gel electrophoresis methods for Burkholderia species.

  2013cites this paper
• Burkholderia pseudomallei Isolates from Sarawak, Malaysian Borneo, Are Predominantly Susceptible to Aminoglycosides and Macrolides

  2013cites this paper
• A heterodimer comprised of two bovine lactoferrin antimicrobial peptides exhibits powerful bactericidal activity against Burkholderia pseudomallei

  2013cites this paper
• Substrate spectrum extension of PenA in Burkholderia thailandensis with a 2 single amino acid deletion Glu 168 del 3 4

  2012cites this paper
• Twelve Positions in a β-Lactamase That Can Expand Its Substrate Spectrum with a Single Amino Acid Substitution

  2012cites this paper
• Design of Primers for Detection and Typing of β-Lactamase Genes from Pathogenic Species of Burkholderia

  2012cites this paper
• Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.

  2012cites this paper
• Substrate Spectrum Extension of PenA in Burkholderia thailandensis with a Single Amino Acid Deletion, Glu168del

  2012cites this paper
• A Review of its Antibacterial Activity , Pharmacokinetic Properties and Therapeutic Use

  2012cites this paper
• Characterization of Ceftazidime Resistance Mechanisms in Clinical Isolates of Burkholderia pseudomallei from Australia

  2012cites this paper
• The biogeography of melioidosis

  2012cites this paper
• The identification and characterisation of novel antimicrobial targets in Burkholderia pseudomallei

  2012influential citation
• The effect of glibenclamide on the pathogenesis of melioidosis

  2012cites this paper
• Polysaccharide Specific Monoclonal Antibodies Provide Passive Protection against Intranasal Challenge with Burkholderia pseudomallei

  2012cites this paper
• Development of Vaccines Against Burkholderia Pseudomallei

  2011influential citation
• Adaptation and Antibiotic Tolerance of Anaerobic Burkholderia pseudomallei

  2011cites this paper
• Molecular Phylogeny of Burkholderia pseudomallei from a Remote Region of Papua New Guinea

  2011cites this paper
• Involvement of the Efflux Pumps in Chloramphenicol Selected Strains of Burkholderia thailandensis: Proteomic and Mechanistic Evidence

  2011cites this paper
• Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei

  2011cites this paper
• Cloning, purification and crystallographic analysis of a hypothetical protein, BPSL1549, from Burkholderia pseudomallei.

  2011cites this paper
• Melioidosis-Reactivation of Latent Disease: Case Presentation and Review

  2011cites this paper
• Characterization of a genetic locus in Burkholderia pseudomallei encoding a putative biofilm-associated protein

  2011cites this paper
• CHAPTER 33 – Melioidosis

  2011cites this paper
• Survey of Antimicrobial Resistance in Clinical Burkholderia pseudomallei Isolates over Two Decades in Northeast Thailand

  2011cites this paper
• Present and future therapeutic strategies for melioidosis and glanders

  2010cites this paper
• Growing Burkholderia pseudomallei in Biofilm Stimulating Conditions Significantly Induces Antimicrobial Resistance

  2010cites this paper
• Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells

  2010cites this paper
• Burkholderia spp. and Related Genera

  2010cites this paper
• Exploring the HME and HAE1 efflux systems in the genus Burkholderia

  2010cites this paper
• Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis.

  2010cites this paper
• Melioidosis and Glanders as Possible Biological Weapons

  2009cites this paper
• RECENT ADVANCES IN BIOMEDICAL SCIENCES OF BURKHOL-

  2009cites this paper
• Defense Against Biological Weapons (Biodefense)

  2009cites this paper
• Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin

  2009cites this paper
• La mélioïdose: une maladie tropicale en quête de reconnaissance

  2009cites this paper
• Burkholderia pseudomallei : une bactérie à ne pas méconnaître

  2009cites this paper
• VACCINE DEVELOPMENT AGAINST PLAGUE, GLANDERS AND MELIOIDOSIS IN THE FORMER SOVIET UNION IN COMPARSION TO THE CURRENT STATE OF GLOBAL KNOWLEDGE

  2009cites this paper
• Variations in Ceftazidime and Amoxicillin-Clavulanate Susceptibilities within a Clonal Infection of Burkholderia pseudomallei

  2009cites this paper
• Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.

  2009cites this paper
• Dosing Regimens of Cotrimoxazole (Trimethoprim-Sulfamethoxazole) for Melioidosis

  2009cites this paper
• In silico analysis of potential diagnostic targets from Burkholderia pseudomallei.

  2008cites this paper
• A Simple Scoring System to Differentiate between Relapse and Re-Infection in Patients with Recurrent Melioidosis

  2008cites this paper
• Epidemiology and Clinical Outcome of Melioidosis at Chonburi Hospital , Thailand

  2008cites this paper
• Determinants of Recurrent Melioidosis

  2008cites this paper